Sale!

ABILIFY Drug Profile, 2020

$499.00 $299.00

ABILIFY Drug Profile, 2020

This report focuses on ABILIFY and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources
SKU: 021436 Category:

Description

ABILIFY Drug Profile, 2020

This report focuses on ABILIFY and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

Contents

  • Profile for ABILIFY
  • US Patents
  • US Regulatory Exclusivity
  • Expired US Patents
  • Paragraph IV Patent Challenges
  • US District Court Litigation
  • US Patent Trial and Appeal Board Cases
  • International (exUS) Patents
  • Supplementary Protection Certificates
  • Clinical Trials
  • Drug Prices – Average Pharmacy Cost
  • Drug Prices – Best Wholesale Price
  • Annual Sales Revenues
  • Finished Product Suppliers
  • Bulk API Sources